Total Visits

Views
A personalized medicine ex vivo test to predict clinical response to first line induction therapy with idarubicin and cytarabine in patients with acute myeloid leukemia57

Select a period of time:

Views

Views
July 202524
August 20255
September 20256
October 20251
November 20252
December 20254
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil14
United Kingdom3
Argentina3
Chile2
Algeria1
Mexico1
South Africa1
 

Top cities views

Views
Santiago2
Dallas2
Barueri1
Basildon1
Brasília1
Buarque de Macedo1
Buenos Aires1
Caruaru1
Chester1
Chicago1